معرفی
Emanuela Berrino is a Researcher at Link Campus University in Rome. Her work focuses on drug design, enzymology, and biochemistry, particularly targeting carbonic anhydrase inhibitors and CO-releasing molecules. She investigates their applications in diseases like rheumatoid arthritis, neurodegeneration, and cancer. Recent studies include pH-sensitive prodrugs, superacid-synthesized compounds, and multitarget therapeutics. Her research combines experimental and computational methods, emphasizing enzyme inhibition mechanisms and therapeutic efficacy.
Education details and lab affiliations are not explicitly mentioned in the provided text. Her articles highlight collaborations in pharmacological profiling, molecular modeling, and in vivo/in vitro testing. She has explored novel inhibitors for carbonic anhydrase isoforms IX/XII and angiotensin-converting enzyme, with applications in glaucoma, epilepsy, and obesity management.
Her work also involves advanced synthesis techniques like microwave-assisted methods and the development of drug delivery systems such as thermosensitive gels. Future directions likely include optimizing CO-releasing hybrids and exploring enzyme mechanisms in diatoms and bacteria.
